Meg Jardine's Publications

About Meg Jardine's Publications

Honorary Professorial Fellow, The George Institute for Global Health
  • Associate Professor, Faculty of Medicine, UNSW Sydney

  • Risk factors for incident kidney disease in older adults: an Australian prospective population-based study

    Internal Medicine Journal Date published:

  • Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY disease (CLARITY): statistical analysis plan for a randomised controlled Bayesian adaptive sample size trial

    Trials Date published:

  • A Novel Risk Prediction Model for Severe Acute Kidney Injury in Intensive Care Unit Patients Receiving Fluid Resuscitation

    Frontiers in Cardiovascular Medicine Date published:

  • Comparative effectiveness of SGLT2i versus GLP1-RA on cardiovascular outcomes in routine clinical practice

    International Journal of Cardiology Date published:

  • Premature Death in Kidney Transplant Recipients: The Time for Trials is Now

    Journal of the American Society of Nephrology Date published:

  • Prior Cardiovascular Treatments-A Key Characteristic in Determining Medication Adherence After an Acute Myocardial Infarction

    Frontiers in Pharmacology Date published:

  • Potential Effects of Elimination of the Black Race Coefficient in eGFR Calculations in the CREDENCE Trial

    Clinical Journal of the American Society of Nephrology Date published:

  • INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-7 PREDICTS CARDIOVASCULAR AND RENAL OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE: THE CREDENCE TRIAL

    Journal of the American College of Cardiology Date published:

  • Antiplatelet agents for chronic kidney disease

    Cochrane Database of Systematic Reviews Date published:

  • SGLT2 inhibitors and finerenone: one or the other or both?

    Nephrology Dialysis Transplantation Date published:

  • SGLT2 inhibitors may prevent diabetes

    Nature Reviews Nephrology Date published:

  • Canagliflozin and Kidney-Related Adverse Events in Type 2 Diabetes and CKD: Findings From the Randomized CREDENCE Trial

    American Journal of Kidney Diseases Date published:

  • GLP-1 receptor agonist versus DPP-4 inhibitor and kidney and cardiovascular outcomes in clinical practice in type-2 diabetes

    Kidney International Date published:

  • POS-019 A NOVEL RISK PREDICTION MODEL FOR SERVE ACUTE KIDNEY INJURY IN INTENSIVE CARE UNIT PATIENTS RECEIVING FLUID RESUSCITATION

    Kidney International Reports Date published:

  • POS-527 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Atrasentan in Patients with IgA Nephropathy (The ALIGN Study)

    Kidney International Reports Date published:

  • Sex differences in chronic kidney disease prevalence in Asia: a systematic review and meta-analysis

    Clinical Kidney Journal Date published: